ALOX12 and Alzheimer disease: Taken together, WFDC12 may activate the ALOX12/15 pathway in AA metabolism by affecting the activity of epidermal PAF-AH and CYP 4F14, thus promoting the accumulation of relevant inflammatory lipid mediators and participating in the regulation of AD pathogenesis and progression.